ENTA
ENANTA PHARMACEUTICALS INC
Pharmaceutical Preparations- 売上
- $65m
- 時価総額
- $270m
株価 $12.61 · 100株 1,261円
| 期 | 23/09 | 24/09 | 25/09 |
|---|---|---|---|
| 売上 | $79m | $68m | $65m |
| 成長率 | — | ▲14.6% | ▲3.4% |
| 総利益 | — | — | — |
| 総利益率 | — | — | — |
| 販管費 | $53m | $58m | $44m |
| 販管費率 | 66.8% | 85.5% | 67.3% |
| 営利 | ▲$137m | ▲$122m | ▲$85m |
| 営利率 | ▲173.2% | ▲179.9% | ▲130.7% |
| 純利益 | ▲$134m | ▲$116m | ▲$82m |
| PBR | 1.2 | 2.1 | 4.2 |
| PSR | 3.4 | 4.0 | 4.1 |
| PGPR | — | — | — |
| PER | — | — | — |
| ネットキャッシュ | $85m | $37m | $32m |
| EV/EBITDA | — | — | — |
| Rule of 40 | — | ▲195% | ▲134% |
| セールス効率 | — | — | — |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
